Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-11

Clinical Trial Update: Islatravir and Methadone Pharmacokinetics (MK-8591-029) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating islatravir (MK-8591) in individuals taking methadone; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Islatravir (Islatravir)
  • Methadone (methadone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2023-12-11